This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
I spent a long time in OCD therapy and learned a lot about the field. Doctors became hypnotized by the appearance of “science”, even if the literature they consulted was essentially pharmaceutical advertising. Such optimism would be disappointed by dwindling pharmaceutical progress in the later half of the century.
Psychiatric survivor and Shield volunteer Andrea Barnes told Mad in America that she was horrified to learn that Catholic Charities was heavily implicated in Russell’s case. “To Somatics LLC marked a watershed moment for advocates who have fought for decades for ECT device manufacturer accountability.
Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. You can learn more about Russell and his book on his website at RussellBishop.com.
Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst.
With the explosion of more and more drugs in cabinets across the country, more and more children are dying—but still, pharmaceutical companies push their products, leading to yet more drugs and yet more deaths. Unlike the pharmaceutical industry, in our village community the pain of losing a single child was felt by all.
For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. The marketing of medical conditions has become a key plank of pharmaceutical industry marketing. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products.
Medical device sales tax – this tax on the sale of certain taxable medical devices will indirectly increase health insurance costs as manufacturers raise prices to cover the tax. Pharmaceuticalmanufacturer excise tax – annual fee on entities engaged in the business of manufacturing or importing branded prescription drugs.
The timing was good, ASHA's PBM contract is out to bid and I've spent the last four months learning what I need to know to evaluate our options. I was happy to share what I've learned and will summarize what I shared here as well with links to some of the things I mentioned. 3 Evaluate your contract terms.
In the process, he learned a lot about what the community needed and the role which digital ignorance played, and made it his business to understand the problems, know what resources were available and find solutions. James believes that we have all learned significant lessons in our lives that will ultimately serve us. David Kurz.
Recently, I had the opportunity to moderate a panel at SXSW discussing the healthcare pink tax, sharing some new research from GoodRx on the disparities, and learning what actions healthcare leaders are taking to address this.
As you will learn, Lohrenz is a world-class leader, author, speaker and changemaker who is a pioneer in the world of aviation. Their entrepreneurial ventures and leadership roles are rooted in a deep belief that there is always more to learn, more to achieve and more ways to make a positive impact.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content